Your browser doesn't support javascript.
Implementation of rapid and frequent SARS-CoV2 antigen testing and response in congregate homeless shelters.
Aranda-Díaz, Andrés; Imbert, Elizabeth; Strieff, Sarah; Graham-Squire, Dave; Evans, Jennifer L; Moore, Jamie; McFarland, Willi; Fuchs, Jonathan; Handley, Margaret A; Kushel, Margot.
  • Aranda-Díaz A; Department of Bioengineering, Stanford University, Stanford, California, United States of America.
  • Imbert E; Division of HIV, ID and Global Medicine, University of California, San Francisco, California, United States of America.
  • Strieff S; Division of HIV, ID and Global Medicine, University of California, San Francisco, California, United States of America.
  • Graham-Squire D; UCSF Benioff Homelessness and Housing Initiative, San Francisco, California, United States of America.
  • Evans JL; San Francisco Department of Public Health, San Francisco, California, United States of America.
  • Moore J; UCSF Benioff Homelessness and Housing Initiative, San Francisco, California, United States of America.
  • McFarland W; UCSF Center for Vulnerable Populations, University of California, San Francisco, California, United States of America.
  • Fuchs J; UCSF Benioff Homelessness and Housing Initiative, San Francisco, California, United States of America.
  • Handley MA; UCSF Center for Vulnerable Populations, University of California, San Francisco, California, United States of America.
  • Kushel M; San Francisco Department of Public Health, San Francisco, California, United States of America.
PLoS One ; 17(3): e0264929, 2022.
Article in English | MEDLINE | ID: covidwho-1938420
ABSTRACT

BACKGROUND:

People experiencing homelessness who live in congregate shelters are at high risk of SARS-CoV2 transmission and severe COVID-19. Current screening and response protocols using rRT-PCR in homeless shelters are expensive, require specialized staff and have delays in returning results and implementing responses.

METHODS:

We piloted a program to offer frequent, rapid antigen-based tests (BinaxNOW) to residents and staff of congregate-living shelters in San Francisco, California, from January 15th to February 19th, 2021. We used the Reach-Effectiveness-Adoption-Implementation-Maintenance (RE-AIM) framework to evaluate the implementation.

RESULTS:

Reach We offered testing at ten of twelve eligible shelters. Shelter residents and staff had variable participation across shelters; approximately half of eligible individuals tested at least once; few tested consistently during the study. Effectiveness 2.2% of participants tested positive. We identified three outbreaks, but none exceeded 5 cases. All BinaxNOW-positive participants were isolated or left the shelters. Adoption We offered testing to all eligible participants within weeks of the project's initiation. Implementation Adaptations made to increase reach and improve consistency were promptly implemented. Maintenance San Francisco Department of Public Health expanded and maintained testing with minimal support after the end of the pilot.

CONCLUSION:

Rapid and frequent antigen testing for SARS-CoV2 in homeless shelters is a viable alternative to rRT-PCR testing that can lead to immediate isolation of infectious individuals. Using the RE-AIM framework, we evaluated and adapted interventions to enable the expansion and maintenance of protocols.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Ill-Housed Persons / COVID-19 Serological Testing / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0264929

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Ill-Housed Persons / COVID-19 Serological Testing / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2022 Document Type: Article Affiliation country: Journal.pone.0264929